Medicare Enrolled

Dr. Jeffrey Alloway, MD

Rheumatology · Greenville, NC
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
1850 W ARLINGTON BLVD, Greenville, NC 27834
2527526101
Registered in NPPES since 2005
NPI: 1104829332 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Alloway from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Alloway? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Alloway

Dr. Jeffrey Alloway is a rheumatology specialist in Greenville, NC, with 21 years of NPI registration. Based on federal Medicare data, Dr. Alloway performed 4,743 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Alloway received a total of $64,458 from 35 pharmaceutical and/or device companies across 602 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Alloway is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 21 years of NPI registration ▲ 4,743 Medicare services $64,458 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
4,743
Medicare services
Bottom 46% in NC for rheumatology
Not available
Unique patients (not deduplicated)
$24
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Infliximab infusion (Remicade)
An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose.
2,160 $27 $125
Denosumab injection (Prolia/Xgeva) 1,440 $18 $50
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
148 $51 $191
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
133 $67 $271
Liver function blood test panel 99 $8 $48
Blood creatinine level test
A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function.
99 $5 $18
Complete blood count (CBC) with differential
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells.
99 $8 $29
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
76 $56 $297
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
74 $8 $11
Methylprednisolone acetate injection, 80 mg
An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication.
72 $9 $40
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
63 $35 $138
Normal saline infusion, 250 cc
Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid.
59 $1 $6
Bone density scan (DEXA)
A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures.
46 $16 $62
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
45 $11 $48
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
44 $14 $73
Tuberculosis blood test (gamma interferon)
A blood test that measures the immune system's response to tuberculosis bacteria using gamma interferon levels.
38 $60 $215
Shoulder X-ray, 2+ views
An X-ray imaging test of the shoulder joint using at least two different angles to visualize the bones and surrounding structures.
20 $6 $33
X-ray of lower and sacral spine, minimum of 4 views
An X-ray imaging test of the lower back and sacrum using at least four different angles to visualize the bones and joints.
14 $8 $59
Knee X-ray, 3 views
An X-ray imaging test of the knee joint that captures three different angles to evaluate the bones and surrounding structures.
14 $5 $37
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
48.4% high complexity
35.1% medium
16.5% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$64,458
Total received (2018-2024)
Avg $9,208/year across 7 years
Top 9% in NC for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
35
Companies
602
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$25
2023
$13
2022
$5,880
2021
$3,066
2020
$13,196
2019
$23,418
2018
$18,860

Payments by company (2024)

Boston Scientific Corporation
$25
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
AbbVie, Inc.
$37,834
AbbVie Inc.
$15,744
ABBVIE INC.
$5,880
PFIZER INC.
$997
Amgen Inc.
$873
Novartis Pharmaceuticals Corporation
$606
Genentech USA, Inc.
$350
Janssen Biotech, Inc.
$345
Lilly USA, LLC
$312
UCB, Inc.
$263
Regeneron Healthcare Solutions, Inc.
$236
E.R. Squibb & Sons, L.L.C.
$150
GlaxoSmithKline, LLC.
$123
Celgene Corporation
$120
Horizon Pharma plc
$63
Mallinckrodt Enterprises LLC
$48
Hikma Pharmaceuticals USA
$47
SANOFI-AVENTIS U.S. LLC
$47
FIDIA PHARMA USA INC.
$43
Radius Health, Inc.
$43
Horizon Therapeutics plc
$39
Boston Scientific Corporation
$38
Alexion Pharmaceuticals, Inc.
$36
Mallinckrodt LLC
$31
Actelion Pharmaceuticals US, Inc.
$30
Boehringer Ingelheim Pharmaceuticals, Inc.
$28
MEDEXUS PHARMA, INC.
$27
DePuy Synthes Sales Inc.
$16
MEDAC PHARMA, INC.
$15
Antares Pharma, Inc.
$14
Janssen Scientific Affairs, LLC
$14
Merck Sharp & Dohme Corporation
$13
Ironwood Pharmaceuticals, Inc
$12
Takeda Pharmaceuticals U.S.A., Inc.
$12
BOSTON SCIENTIFIC CORPORATION
$11
Top 3 companies account for 92.2% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AVSOLA · Actemra · BENLYSTA · COSENTYX · Cimzia · DUZALLO · EVENITY · Enbrel · FORTEO · HUMIRA · HYALGAN · Humira · Hymovis · INFLECTRA · KEVZARA · KEVZARA SARILUMAB INJECTION · KRYSTEXXA · LYRICA · MONOVISC · Mitigare · OFEV · OPSUMIT MACITENTAN · ORENCIA · Otezla · Otrexup · Prolia · RAYOS · RENFLEXIS · RINVOQ · Rasuvo · Resolution 360 ULTRA Clip · Rinvoq · Rituxan · SIMPONI · SIMPONI ARIA · SKYRIZI · STELARA · SYMPHION · SYNVISC-ONE · Strensiq · TALTZ · Tymlos · Uloric · WaveWriter Alpha Prime 16 · XELJANZ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a rheumatology specialist in Greenville?
Compare rheumatologists in the Greenville area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists in nearby ZIP areas
10
County median income
$58,851
Nearest hospital to ZIP centroid (approximate)
ECU HEALTH MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Alloway is a mixed practice specialist, with moderate Medicare volume, with 21 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Alloway experienced with infliximab infusion (remicade)?
Based on Medicare claims data, Dr. Alloway performed 2,160 infliximab infusion (remicade) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Alloway receive payments from pharmaceutical companies?
Yes. Dr. Alloway received a total of $64,458 from 35 companies across 602 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Alloway's costs compare to other rheumatologists in Greenville?
Dr. Alloway's average Medicare payment per service is $24. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Alloway) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →